MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia

K. Abe, T. Hayashi, N. Akiyama, M. Yamamoto, M. Fujita (Nishinomiya, Japan)

Meeting: 2016 International Congress

Abstract Number: 1370

Keywords: Dementia, Dopamine, Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To test usefulness of arterial spin labeling (ASL) perfusion MRI for diagnoses of Parkinson’s disease (PD) with dementia.

Background: Dopamine transporter (DAT) images may be helpful to ascertain existence of defect of DAT in the striatum, but not to give information concerning to cerebral blood flow (CBF) that is needed to diagnose PD with dementia.

Methods: Fifty-five PD patients (20 Male/25 Female, Age 70.2±5.7 (mean±SD) years, disease duration7.55±3.3) who met a Japanese PD diagnosis criteria and 35 age and sex normal controls were scanned by using a pseudo-continuous arterial spin labeling (PCASL) method with a 1.5 Tesla MRI unit (Achieva A-series; Philips Medical Systems, Best, The Netherlands). Regional CBF was compared in the frontal, the parietoposterial, and the posterior cortex using region-of-interest analysis. In addition, evaluation of DAT images were conducted by a single photon emission computed tomography (SPECT) device (Bright View, Philips, Amsterdam, Netherlands) using 123I-N-w-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane (123I-FP-CIT). Clinical signs were evaluated by Hoehn-Yahr stage, unified Parkinson’s disease rating scale (UPDRS), minimental state examination (MMSE), frontal assessment battery (FAB) and the Montreal cognitive assessment (MOCA).

Results: PD patients showed reduced DAT uptakes in the striatum that confirm diagnoses of PD. PD patients had UPDRS with 33.9±5.2 MMSE with 24.0±3.9, FAB with 13.5±3.7, MOCA with 21.7±5.7. PD patients showed four regional CBF patterns. The first group had normal regional CBF patterns comparing with those of normal controls. The second group had reduced frontal cortex regional CBF patterns comparing with those of normal controls. The third group had reduced parietoposterial cortex regional CBF patterns comparing with those of normal controls. The fourth group had reduced posterial cortex regional CBF patterns comparing with those of normal controls. Result of cognitive examinations were demonstrated in the Figure 1.

Conclusions: This is a study to detect four patterns of hypoperfusion in the cortex in PD patients with dementia using ASL perfusion MRI. Because ASL perfusion MRI is completely noninvasive and can, therefore, safely be used for repeated assessments, this method can compensate for monitoring of PD patients with dementia.

To cite this abstract in AMA style:

K. Abe, T. Hayashi, N. Akiyama, M. Yamamoto, M. Fujita. Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/arterial-spin-labeling-perfusion-mri-compensate-for-other-diagnostic-tools-in-evaluation-of-parkinsons-disease-with-dementia/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/arterial-spin-labeling-perfusion-mri-compensate-for-other-diagnostic-tools-in-evaluation-of-parkinsons-disease-with-dementia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley